TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Intelligibility measured by Percent of words correctly identified
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of specific antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Kinetics of specific antibody titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Subjective appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in time to perform the procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Response to platinum-based chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum concentrations (Cmax) for plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the curve from time 0 to infinity (AUC0-inf) for plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the curve from time 0 to the last time point (AUC0-t) for plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with Blood stream infections
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of surgical reintervention
Endpoint domain: Adverse events/effects
Primary endpoint: decrease in quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change of serum progesterone levels referenced to ovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Change of reproductive hormone levels referenced to ovulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Resolution on SBO
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teeth Hypersensitivity change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Montreal Cognitive Assessment scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Safety of Skyvaricella Injection
Endpoint domain: Adverse events/effects
Primary endpoint: Risk of C. difficile infection
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of subjects tolerating full challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Micro-vascular densities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Cervical dilation speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expulsive time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with lorlatinib-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of training sessions during which urine leakage occurred
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Patient's global impression of improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient's global satisfaction with treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: length of stay (LOS) in days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Total Length of Stay (TLOS)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Change in knee joint pain subscale from WOMAC questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in knee joint subjective pain rating using a VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Physician Global Assessment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Resolution of Metabolic Acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Final Seroconversion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total morphine consumption postoperative
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1 Year Progression-free Survival Rate (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: inter-epicanthal distance (IED)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LS diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cerebral reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: peripheral vascular reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rubidium PET image quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: JMDRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of esophageal injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of intracerebral hemorrhage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: first time to bowel sound
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: beginning of breastmilk lactation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Montreal cognitive assessment scale (MoCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Subjective cognitive decline questionnaire (SCD questionnaire 9, SCD-9)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: clinical performance (AUC, sensitivity, specificity, tissue of origin)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Explosive Power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ∆RASrFC value in echocardiography after a fluid challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Breastfeeding difficulties
Endpoint domain: Adverse events/effects
Primary endpoint: KCCQ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Post-surgical pain control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of HF Hospitalizations and Emergency Ward accesses
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement of Functional Capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Horizontal displacement measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical Displacement measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Body Mass Index Z-Scores (BMI-z)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Safety of intraoperative FCV
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Study Drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Attain Maximum Plasma Concentration (tmax) for Study Drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration-time Curve From Time Zero to Dosing Interval (AUC0-τ) for Study Drug
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Radiation exposure to the physician
Endpoint domain: Adverse events/effects
Primary endpoint: Safety and tolerability of EDP-322
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in functional capacity and muscle strength - handgrip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in functional and cardiopulmonary capacity - 6-minute walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Sarcopenia - muscle strength and performance assessment using Time Up and Go Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in patient-reported average daily pain
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Anti-Müllerian hormone (AMH) levels in women
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in sperm motility count in men
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prediction accuracy of noninvasive methods for esophageal varices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: No secondary surgical intervention per protocol definition
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Menopausal symptom changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient health outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Right/left discrimination ability
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Highest SOFA score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tinnitus impact
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Patient health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of participants achieving SRI-4 at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in scores on the Gastrointestinal Symptom Rating Scale (GSRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total IV fluids administered
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Adequate number of cells for diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Complete closure of the Venous Leg Ulcer (VLU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Prediction of the extension of recurrences of high-grade gliomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: MSM awareness of anal cancer risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: MSM awareness of strategies to decrease anal cancer risk
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Electrocardiogram (ECG) measures from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intestinal preparation cleanliness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Malondialdehyde (MDA) as oxidative stress marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interlukin 6 (IL-6) as inflammatory marker
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Plasma Neurotensin (NT) as potential marker for neuropathic pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change on Self-Efficacy Questionnaire (SEQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change on Satisfaction with Life Scale (SWLS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in pain intensity on visual analogue scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in range of motion assessed with universal goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain Outcome
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Unpleasant Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inflammatory cytokine markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Headache relief in 2 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional disability level in 2 hours
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Maximal dynamic strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional test - 30-s Chair-stand test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IL-10 mediated STAT3 phosphorylation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: endometrial gene expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in faecal metabolites
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Profile/composition of the gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Jebsen Taylor Test of Hand Function (JTHF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ctDNA Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in incidence of graft vs. host disease (GVHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in severity of acute graft vs. host disease (GVHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in severity of chronic graft vs. host disease (GVHD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in incidence of relapse-free mortality (transplant-related mortality)
Endpoint domain: Mortality/survival
Primary endpoint: Change in disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Opioid analgesic consumption
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Adverse events according to NCI-CTCAE v5.0
Endpoint domain: Adverse events/effects
Primary endpoint: Dyspareunia Alleviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Modified Borg Dyspnea Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Settled Angina Questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Changes in low back pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Kinesiophobia
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Uptake of 11C-ER 176
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: first analgesic need times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathologic characteristic
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional retinal changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in skin symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in skin lesion area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Adherence to IMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of technical issues
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Vaginal swab results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Quality of the operative field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Early adiposity rebound (EAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Overweight and obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Gross Motor Milestone Development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Long-term Retention
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change in emotional composition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Composite GI symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: CXCR4 PET-derived uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: local tolerance (injection site reactions)
Endpoint domain: Adverse events/effects
Primary endpoint: Clinically significant changes from baseline in ECG, vital signs and safety laboratory assessments
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of sedation (Modified Observer's Assessment of Alertness and Sedation [MOAA/S])
Endpoint domain: Adverse events/effects
Primary endpoint: Change from baseline in Clinician Administered Dissociative States Scale (CADSS)
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of subject-discharge readiness at discharge on Day 0
Endpoint domain: Adverse events/effects
Primary endpoint: Tumor infiltrating lymphocytes (TIL) Density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 6-month Progression-Free Survival (PFS6)
Endpoint domain: Mortality/survival
Primary endpoint: Success of Organ Transplantations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electrophysiological recordings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: visualization of the major branches of the facial nerve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of appendiceal neoplasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: NNT of IA for the appendiceal neoplasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Clinical Decision Support Performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive rate of SIBO
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Rate of in-hospital procedures with fluid loss from sweat of >500 ml/session
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidences of Device and treatment-related AEs and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Symptomatic changes in vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional capacity using the ADL-Glittre test (TGlittre)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in EEG-fNIRS performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental health symptoms: depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mental health symptoms: anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Changes in Cobb ankle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in maximum Ankle Trunk Rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Changes in quality of life with SRS - 22 questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Observation of at least one adverse effect
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of complete or almost complete reepithelialisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: duration of intubation procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of written do-not-intubate and -resuscitate (DNIR) order
Endpoint domain: Mortality/survival
Primary endpoint: Change in Individual Alpha Frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Visual Attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Visual Perception
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants with Serious Adverse Events (SAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of 111In panitumumab
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients with a hospital re-admission
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: APGAR scores of newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnant Women's Birth Satisfaction Scale (BSS) mean scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in maternal drug relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Opioid use treatment continuation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Sum of Disability Adjusted Life Years
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of Healthcare Events
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Hip Range of Motion (Degrees)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in The Crisis Prevention Index scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Proportion of potentially PrEP eligible patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use